| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 536 | $22.27 | $11,936.72 | -0.2% | +21.6% | - | |
| Jul 7, 2025 | CBLL Ceribell, Inc. | Chao Xingjuan54 | President And CEO | Sell | 25,000 | $17.70 | $442,500.00 | -3.1% | -26.9% | - | |
| Jul 7, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 877 | $22.27 | $19,530.79 | -0.5% | +21.6% | - | |
| Jul 7, 2025 | SIBN Si-Bone, Inc. | Francis Laura70 | Chief Executive Officer | Sell | 757 | $18.26 | $13,822.82 | -0.2% | -19.6% | - | |
| Jul 3, 2025 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.63 | Chief Legal Officer | Sell | 9,160 | $4.17 | $38,233.84 | -3.3% | -20.4% | - | |
| Jul 3, 2025 | SGHT Sight Sciences, Inc. | Badawi David59 | Chief Technology Officer | Sell | 5,679 | $4.17 | $23,704.15 | -0.3% | -20.4% | - | |
| Jul 3, 2025 | INCY Incyte Corp | Flannelly Barry P50 | EVP &General Manager Us | Sell | 10,903 | $68.15 | $743,039.45 | -21.5% | +26.7% | - | |
| Jul 3, 2025 | INCY Incyte Corp | Iyengar Vijay K62 | EVP, Gmapps | Sell | 8,617 | $68.15 | $587,275.37 | -9.6% | +26.7% | - | |
| Jul 2, 2025 | OFIX Orthofix Medical Inc. | Engine Capital Management, LP | 10% Owner | Buy | 1,250 | $11.11 | $13,881.25 | - | +32.4% | - | |
| Jul 2, 2025 | SGHT Sight Sciences, Inc. | Bauerlein Alison73 | Chief Financial Officer | Sell | 19,260 | $4.10 | $78,927.48 | -3.0% | -17.3% | - | |
| Jul 2, 2025 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 945 | $255.49 | $241,438.05 | -1.4% | +7.0% | - | |
| Jul 2, 2025 | IRTC Irhythm Holdings, Inc. | Turakhia Minang46 | EVP, CMO &CSO | Sell | 1,420 | $145.41 | $206,482.20 | -3.3% | +20.5% | - | |
| Jul 2, 2025 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 5,005 | $18.34 | $91,810.59 | -0.8% | -20.1% | - | |
| Jul 2, 2025 | INCY Incyte Corp | Denton Sheila A. | EVP &General Counsel | Sell | 599 | $68.61 | $41,097.39 | -2.2% | +24.4% | - | |
| Jul 2, 2025 | SGHT Sight Sciences, Inc. | Link Matthew66 | Chief Commercial Officer | Sell | 4,889 | $4.10 | $20,035.12 | -0.6% | -17.3% | - | |
| Jul 2, 2025 | SIBN Si-Bone, Inc. | Pisetsky Michael A.68 | SVP, Ops &Adm/ Chief Legal Ofr | Sell | 3,127 | $18.29 | $57,202.88 | -0.4% | -20.1% | - | |
| Jul 2, 2025 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 3,310 | $18.27 | $60,475.89 | -0.6% | -20.1% | - | |
| Jul 1, 2025 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $252.70 | $151,621.65 | -0.1% | +0.4% | - | |
| Jul 1, 2025 | SGHT Sight Sciences, Inc. | Badawi Paul62 | President And CEO | Sell | 23,637 | $4.15 | $98,140.82 | -0.4% | -14.5% | - | |
| Jul 1, 2025 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 66 | $256.99 | $16,961.34 | -0.8% | +5.8% | - | |
| Jul 1, 2025 | ESTA Establishment Labs Holdings Inc. | Jw Asset Management, LLC65 | 10% Owner | Sell | 9,700 | $44.38 | $430,486.00 | -0.3% | -4.7% | - | |
| Jul 1, 2025 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 50,000 | $22.04 | $1,102,000.00 | -63.7% | +27.1% | - | |
| Jul 1, 2025 | MASI Masimo Corp | Masimo Corp | 10% Owner | Sell | 821,327 | $2.25 | $1,847,985.75 | -100% | -15.4% | - | |
| Jul 1, 2025 | BSX Boston Scientific Corp | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Sell | 50,000 | $106.97 | $5,348,315.00 | -21.9% | -7.4% | - | |
| Jul 1, 2025 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 3,883 | $256.99 | $997,892.17 | -4.4% | +5.8% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.